Effect of inhibitory action of LY294002 in the PI3K/AKT signaling pathway on gastric adenocarcinoma SGC-7901 cells
Jing Han,Qingyu Zhang,Chunsheng Kang,Jiabei Xie,Yanchao Fu,Jing Zhang,Feifei Ma,Tao Wang
DOI: https://doi.org/10.3969/j.issn.1000-8179.2011.05.004
2011-01-01
Chinese Journal of Clinical Oncology
Abstract:Objective: To observe the effects of phosphatidyl creatine 3-kinase (PI3K) inhibitor LY294002 on the PI3K/Serine Threonine Kinases (AKT) signal pathway, cell growth, cell invasion and apoptosis in human gastric adenocarcinoma SGC-7901 cells. Methods: Human gastric carcinoma SGC-7901 cells were treated with LY294002, and Western blot was used to detect the expression of proteins in the P13K pathway including P-AKT, matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), B-cell lymphoma/leukemia (Bcl-2) and Cyclin D1. Proliferation, invasion and apoptosis were detected by MTT, Transwell assay and flow cytometry. Results: Compared with SGC-7901 cells in the control group and DMSO group, LY294002 significantly downregulated the expression of P-AKT, MMP-2, MMP-9, Bcl-2 and CylinD1. Proliferative activity was suppressed in the cells treated with LY294002 starting on the second day, with an obvious decrease in viability (P < 0.05). The results of the Transwell assay showed that the number of cells travelling through the matrigel was 81.0±2.65 in the control group, 81.3±1.52 in the DMSO group, and 44.6±2.52 in the LY294002 group. There were statistical differences among the three groups (F = 255.1, P = 0.000). The flow cytometry results showed that there was G 0/G1 arrest in the LY294002 group (χ2 = 18.729, P = 0.016). The percentage of apoptotic cells was increased when SGC-7901 cells were treated with LY294002 (F = 149.66, P = 0.000). Conclusion: LY294002 inhibits the PI3K/AKT signal transduction pathway. LY294002 can effectively downregulate downstream protein expression, inhibit proliferation and invasion of SGC-7901 cells and increase apoptosis.